This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,566,364,958 tablets of the antibiotic medication moxifloxacin hydrochloride 400 mg. The $22,742.47 firm-fixed-price delivery order contract has a completion date of November 8, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order did not have a set-aside designation, indicating open competition. The contract supports the medical needs of military personnel, veterans, and other federal beneficiaries through the DLA's procurement of essential pharmaceutical commodities.
Generated 2/6/25, 9:28 AM